Teva Pharmaceutical Industries Ltd, which owns Watsons’ generics business, has agreed to pay $112 million, a sum that is part of the $157 million the Israeli company in February disclosed it would pay to settle the litigation. The case is among several in recent years targeting “pay-for-delay” settlements, in which brand-name drugmakers resolve patent lawsuits by paying generic manufacturers to keep their products off the market for a longer period.Įndo has agreed to pay a combined $100 million to resolve claims brought by separates classes of direct purchasers of Lidoderm like retailers and so-called end payors for the medication like consumers and insurers. The Joseph Saveri Law Firm, LLP served as Liaison Counsel for Lidoderm end-payors in a class action lawsuit against Endo Pharmaceuticals. ![]() Keep away from children and animals: even a used LIDODERM patch contains a substantial amount of lidocaine. LIDODERM patches should be worn for no more than 12 hours a day. Apply only to intact skin with no blisters. Pharmaceutical Services & Solutions Telehealth. LIDODERM is used to relieve the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain. By the time of the anticompetitive Lidoderm agreement challenged in this complaint. Lidoderm® Lidocaine 5, 700 mg Patch Carton 30 Patches Endo Laboratories 63481068706. was the parent of Endo Pharmaceuticals Inc. At the time of the anticompetitive Opana ER agreement challenged in this complaint, Endo Pharmaceuticals Holdings Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Lidoderm. The accords were disclosed in papers filed in federal court in San Francisco on Tuesday and resolve claims centered on a deal Endo reached in 2012 to settle a patent infringement case it filed against generic drugmaker Watson Pharmaceuticals. Lidocaine is chemically designated as acetamide, 2- (diethylamino)-N- (2,6-dimethylphenyl), has an octanol: water partition ratio of 43 at pH 7.4, and has the following structure: Each adhesive patch contains 700 mg of lidocaine (50 mg per gram adhesive) in an aqueous base. Endo International had 2.9 billion in revenues in 2014. The FTCs complaint alleges that Endo Pharmaceuticals Inc. (Reuters) - Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |